No results found for “”
No results found for filter “”
-
Statements & press releases 05.12.22
Post-code lottery in European diabetes care must be addressed, says EFPIA
Innovation offers the potential to improve health outcomes and quality of life for people living with diabetes. EFPIA is committed to working with all...
Read Article -
Blog articles 01.12.22
Podcast: What would a TRIPS waiver extension mean for diagnostics?
Listen to EFPIA's latest podcast.
Read Article -
Statements & press releases 30.11.22
EFPIA and Vaccines Europe respond to the European Commission's Global Health Strategy
Key areas identified by the Commission are global issues which no sector can address alone.
Read Article -
Blog articles 30.11.22
Digital endpoints for patient-focused health management
Besides providing more precise and accurate assessments, digital endpoints could significantly decrease the time and costs related to trial participation,...
Read Article -
Blog articles 29.11.22
Time for change - caring for the stomach cancer community
To mark Stomach Cancer Awareness Month, we’re dedicated to raising awareness and advocating for change for all of those living with, or caring for, those...
Read Article -
Blog articles 24.11.22
How to improve patient access to novel antibiotics in Europe: Recommendations for policies to fight AMR...
A new report seeks to highlight the significant barriers existing at the national level - related to value-assessment methods and pricing and reimbursement...
Read Article -
Blog articles 23.11.22
What would be the impact of a TRIPS waiver extension? (Guest blog)
Waiving IP would not only attempt to solve a problem that does not exist. It would send a clear message to companies investing in COVID-19 therapeutics...
Read Article -
Blog articles 22.11.22
Medicine shortages: EFPIA proposals for action
9 concrete proposals underpinned by 5 principles to help protect patients across Europe from the impact of shortages across the wider medicines supply...
Read Article -
Blog articles 22.11.22
How research pharmaceutical companies are contributing towards tackling global warming
Understanding the relationship between people, health and the environment is critical to ensuring the pharmaceutical industry, along with other stakeholders,...
Read Article -
Blog articles 21.11.22
Podcast: What would be the impact of a TRIPS waiver extension?
Industry has shown its commitment to work with partners in order to ensure that vaccines and therapies reach patients who need them wherever they are
Read Article -
Statements & press releases 16.11.22
European Cancer Pulse: What is your country doing to beat cancer?
New tool provides data on progress in the fight against cancer, revealing disparities within and between EU Member States
Read Article -
Blog articles 16.11.22
Fighting cancer: the way forward lies with innovation (Guest blog)
An environment that encourages innovation is key to scientific progress. This is the way forward. Let’s make sure that today’s research can be another...
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 07.11.22
Europe’s share of global medicines R&D shrinks by a quarter in 20 years – as sector’s declining trends...
EFPIA is warning that the options being discussed by policy makers in the context of the EU Pharma Strategy fall well short of addressing concerns and...
Read Article -
EFPIA News 05.10.22
Pharmaceutical industry response to the war in Ukraine
Supporting people affected by the war
Read Article -
EFPIA News 16.06.22
European Multi-Stakeholder Sounding Board Meeting on “Innovation – The key to sustainable cancer care”...
Join the sounding board to discuss how high-quality care pathways and innovation can alleviate the pressure, improve sustainable patient access to high...
Read Article -
EFPIA News 24.05.22
RETHINKING Alzheimer’s disease project, calling for change in Alzheimer’s care, kicks off!
Now is the time to rethink Alzheimer’s disease to improve Alzheimer’s disease care pathway and the lives of people living with it.
Read Article -
EFPIA News 02.05.22
Roberta Savli appointed as Executive Director of Public Affairs at EFPIA
Roberta will take on the new role with immediate effect.
Read Article -
EFPIA News 28.04.22
EFPIA Recommendations on a Connected Data System in Europe
A connected health data ecosystem has the potential to empower more effective and efficient research and development of new treatments and diagnostics....
Read Article -
EFPIA News 22.04.22
Implementing “Good Lay Summary Practice”
Final report of the GLSP Workshop held on the 14, 15 & 21 February 2022.
Read Article -
EFPIA News 11.04.22
New proposals from the research-based pharmaceutical industry should reduce inequalities in patient access...
Europe's pharmaceutical sector is stepping up measures to help deliver faster, more equitable access to medicines for millions of patients across the EU....
Read Article -
EFPIA News 06.04.22
Shortening the WAIT - Patient Access to Medicines in Europe
Disparities in the time it takes for patients to access new medicines in different EU Member States are increasing.
Read Article -
EFPIA News 27.01.22
Shifting the paradigm for ATMPs
Adapting reimbursement and value frameworks to improve patient access in Europe
Read Article -
EFPIA News 11.01.22
Stronger Intellectual Property Rights in EU Free Trade Agreements can boost GDP, productivity, investments...
Discover a recent ECIPE report, supported by EFPIA among other industry associations.
Read Article -
EFPIA News 06.01.22
EFPIA publishes the Evidence MIX (Measures, Insights and eXamples) Report
Evaluating the EU Regulatory System, Assessing the Environment, Gaining Direct Experimental Insights, and Offering Policy Recommendations from Innovative...
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 05.12.22
Post-code lottery in European diabetes care must be addressed, says EFPIA
Innovation offers the potential to improve health outcomes and quality of life for people living with diabetes. EFPIA is committed to working with all...
Read Article -
Statements & press releases 30.11.22
EFPIA and Vaccines Europe respond to the European Commission's Global Health Strategy
Key areas identified by the Commission are global issues which no sector can address alone.
Read Article -
Statements & press releases 16.11.22
European Cancer Pulse: What is your country doing to beat cancer?
New tool provides data on progress in the fight against cancer, revealing disparities within and between EU Member States
Read Article -
Statements & press releases 26.10.22
Joint Statement Pharmaceutical industry concerns over the implementation of the EU HTA Regulation
We call for a constructive dialogue with the European Commission and the newly established Coordination Group, to ensure the HTA Regulation meets its intended...
Read Article -
Statements & press releases 26.10.22
Proposals on wastewater treatment will jeopardise patient access to medicines without helping green transition...
The pharmaceutical industry has put in place an extensive Eco-Pharmaco-Stewardship programme which over the past 15 years has made great progress in minimising...
Read Article -
Statements & press releases 20.10.22
Ensuring the full potential of EHDS: Stakeholders’ recommendations on how to make the digital transformation...
Read Article -
Statements & press releases 28.09.22
‘TEE’ system will revitalise antibiotic research and save money for Europe, new evidence shows
New and novel antibiotics are urgently needed to help tackle the global health threat of antimicrobial resistance (AMR), as infections become more resistant...
Read Article -
Statements & press releases 20.09.22
EFPIA and the EFPIA Oncology Platform Congratulate the European Commission on its proposal for a Council...
The Commission’s proposal is an important step forward to ensure people across Europe benefit from the latest innovation in screening and we believe the...
Read Article -
Statements & press releases 13.09.22
Pharmaceutical industry launches patient information initiative for displaced Ukrainians
Allowing Ukrainian refugees in Poland to access information on prescription medicines in Ukrainian via an electronic product information leaflet
Read Article -
Statements & press releases 12.09.22
EFPIA statement on the WHO/Europe Tel Aviv ministerial lunch 12 September 2022
We are looking forward to the continued dialogue and collaboration with WHO/Europe and its Member States and all other stakeholders to achieve our common...
Read Article -
Statements & press releases 05.09.22
Pharmaceutical companies to give evidence on responses to Covid-19
European Parliament Committee to hear how strong collaboration and deep research knowledge enabled a swift response to mitigate the devastating impact...
Read Article -
Statements & press releases 26.07.22
EFPIA statement on the EU-Turkey WTO Case on Pharmaceuticals
We reiterate our position in favour of an open and rules-based trading system which best supports the resilience and efficiency of global pharmaceutical...
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 01.12.22
Podcast: What would a TRIPS waiver extension mean for diagnostics?
Listen to EFPIA's latest podcast.
Read Article -
Blog articles 30.11.22
Digital endpoints for patient-focused health management
Besides providing more precise and accurate assessments, digital endpoints could significantly decrease the time and costs related to trial participation,...
Read Article -
Blog articles 29.11.22
Time for change - caring for the stomach cancer community
To mark Stomach Cancer Awareness Month, we’re dedicated to raising awareness and advocating for change for all of those living with, or caring for, those...
Read Article -
Blog articles 24.11.22
How to improve patient access to novel antibiotics in Europe: Recommendations for policies to fight AMR...
A new report seeks to highlight the significant barriers existing at the national level - related to value-assessment methods and pricing and reimbursement...
Read Article -
Blog articles 23.11.22
What would be the impact of a TRIPS waiver extension? (Guest blog)
Waiving IP would not only attempt to solve a problem that does not exist. It would send a clear message to companies investing in COVID-19 therapeutics...
Read Article -
Blog articles 22.11.22
Medicine shortages: EFPIA proposals for action
9 concrete proposals underpinned by 5 principles to help protect patients across Europe from the impact of shortages across the wider medicines supply...
Read Article -
Blog articles 22.11.22
How research pharmaceutical companies are contributing towards tackling global warming
Understanding the relationship between people, health and the environment is critical to ensuring the pharmaceutical industry, along with other stakeholders,...
Read Article -
Blog articles 21.11.22
Podcast: What would be the impact of a TRIPS waiver extension?
Industry has shown its commitment to work with partners in order to ensure that vaccines and therapies reach patients who need them wherever they are
Read Article -
Blog articles 16.11.22
Fighting cancer: the way forward lies with innovation (Guest blog)
An environment that encourages innovation is key to scientific progress. This is the way forward. Let’s make sure that today’s research can be another...
Read Article -
Blog articles 16.11.22
Patients are key to rethinking diabetes care (Guest blog)
Integrated IT and finance systems can drive a new era of person-centred care delivery
Read Article -
Blog articles 16.11.22
Movember: an opportunity for prostate cancer awareness to promote earlier diagnosis (Guest blog)
Overcoming this stigma and breaking down screening barriers is vital and requires education and open conversation.
Read Article -
Blog articles 16.11.22
Movember: a timely reminder of the importance of addressing unmet needs in prostate cancer through partnership...
Movember is an important reminder for men to prioritize their health
Read Article